Compare AGNT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGNT | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | 1834 | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 815.0M | 716.8M |
| IPO Year | N/A | 2016 |
| Metric | AGNT | BVS |
|---|---|---|
| Price | $4.79 | $12.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.5M | 665.5K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $287.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.51 | $5.81 |
| 52 Week High | $5.79 | $11.97 |
| Indicator | AGNT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 74.09 |
| Support Level | N/A | $7.43 |
| Resistance Level | $5.79 | N/A |
| Average True Range (ATR) | 0.32 | 0.56 |
| MACD | -0.02 | 0.33 |
| Stochastic Oscillator | 23.35 | 95.73 |
AGNT Inc is a multi-model real estate platform, with brands including eXp Realty, eXp Commercial, NextHome, FrameVR.io, and SUCCESS Enterprises. The group prioritizes transparency, innovation, and long-term value for agents, franchise owners, staff, and shareholders.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.